Reduced Expression of ZDHHC2 Is Associated with Lymph Node Metastasis and Poor Prognosis in Gastric Adenocarcinoma

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Yan, Shu Mei ^a   Tang, Jian Jun ^a   Huang, Chun Yu ^a   Xi, Shao Yan ^a   Huang, Ma Yan ^a   Liang, Jian Zhong ^a   Jiang, Yuan Xue ^a   Li, Yu Hong ^a   Zhou, Zhi Wei ^a   Ernberg, Ingemar ^b   Wu, Qiu Liang ^a   Du, Zi Ming ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

UNCLASSIFIED DRUG; ZDHHC2 PROTEIN; ZINC FINGER PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH TUMOR;

ACYLTRANSFERASES; ADENOCARCINOMA; DOWN-REGULATION; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84874026361     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056366     Document Type: Article

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
2. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, et al. (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730.
3. Zagouri F, Papadimitriou CA, Dimopoulos MA, Pectasides D, (2011) Molecularly targeted therapies in unresectable-metastatic gastric cancer: a systematic review. Cancer Treat Rev 37: 599-610.
4. Croxtall JD, McKeage K, (2010) Trastuzumab: in HER2-positive metastatic gastric cancer. Drugs 70: 2259-2267.
5. Jang BG, Kim WH, (2011) Molecular pathology of gastric carcinoma. Pathobiology 78: 302-310.
6. Mitchell DA, Vasudevan A, Linder ME, Deschenes RJ, (2006) Protein palmitoylation by a family of DHHC protein S-acyltransferases. J Lipid Res 47: 1118-1127.
7. Linder ME, Deschenes RJ, (2004) Model organisms lead the way to protein palmitoyltransferases. J Cell Sci 117: 521-526.
8. Smotrys JE, Linder ME, (2004) Palmitoylation of intracellular signaling proteins: regulation and function. Annu Rev Biochem 73: 559-587.
9. Ohno Y, Kihara A, Sano T, Igarashi Y, (2006) Intracellular localization and tissue-specific distribution of human and yeast DHHC cysteine-rich domain-containing proteins. Biochim Biophys Acta 1761: 474-483.
10. Oyama T, Miyoshi Y, Koyama K, Nakagawa H, Yamori T, et al. (2000) Isolation of a novel gene on 8p21.3-22 whose expression is reduced significantly in human colorectal cancers with liver metastasis. Genes Chromosomes Cancer 29: 9-15.
11. Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, et al. (1993) Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53: 3869-3873.
12. Emi M, Fujiwara Y, Ohata H, Tsuda H, Hirohashi S, et al. (1993) Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma. Genes Chromosomes Cancer 7: 152-157.
13. Fujiwara Y, Ohata H, Emi M, Okui K, Koyama K, et al. (1994) A 3-Mb physical map of the chromosome region 8p21.3-p22, including a 600-kb region commonly deleted in human hepatocellular carcinoma, colorectal cancer, and non-small cell lung cancer. Genes Chromosomes Cancer 10: 7-14.
14. Ohata H, Emi M, Fujiwara Y, Higashino K, Nakagawa K, et al. (1993) Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma. Genes Chromosomes Cancer 7: 85-88.
15. Knowles MA, Shaw ME, Proctor AJ, (1993) Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 8: 1357-1364.
16. Yaremko ML, Kutza C, Lyzak J, Mick R, Recant WM, et al. (1996) Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer 16: 189-195.
17. Anbazhagan R, Fujii H, Gabrielson E, (1998) Allelic loss of chromosomal arm 8p in breast cancer progression. Am J Pathol 152: 815-819.
18. Li YF, Wang DD, Zhao BW, Wang W, Yuan SQ, et al. (2012) Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR. PLoS One 7: e43555.
19. Wang W, Lv L, Pan K, Zhang Y, Zhao JJ, et al. (2011) Reduced expression of transcription factor AP-2alpha is associated with gastric adenocarcinoma prognosis. PLoS One 6: e24897.
20. Japanese Gastric Cancer A, (1998) Japanese Classification of Gastric Carcinoma- 2nd English Edition. Gastric Cancer 1: 10-24.
21. Du ZM, Hu CF, Shao Q, Huang MY, Kou CW, et al. (2009) Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer 125: 1832-1841.
22. Stanbridge EJ, (1990) Identifying tumor suppressor genes in human colorectal cancer. Science 247: 12-13.
23. Nault JC, Zucman-Rossi J, (2011) Genetics of hepatobiliary carcinogenesis. Semin Liver Dis 31: 173-187.
24. Kanwal R, Gupta S, (2012) Epigenetic modifications in cancer. Clin Genet 81: 303-311.
25. Shibata MA, Liu ML, Knudson MC, Shibata E, Yoshidome K, et al. (1999) Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. EMBO J 18: 2692-2701.
26. Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, et al. (1998) Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 4: 802-807.
27. Giannakis M, Chen SL, Karam SM, Engstrand L, Gordon JI, (2008) Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci U S A 105: 4358-4363.
28. Talmadge JE, Fidler IJ, (2010) AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70: 5649-5669.
29. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
30. Fidler IJ, (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
31. Greaves J, Chamberlain LH, (2011) DHHC palmitoyl transferases: substrate interactions and (patho)physiology. Trends Biochem Sci 36: 245-253.
32. Fukata M, Fukata Y, Adesnik H, Nicoll RA, Bredt DS, (2004) Identification of PSD-95 palmitoylating enzymes. Neuron 44: 987-996.
33. Greaves J, Gorleku OA, Salaun C, Chamberlain LH, (2010) Palmitoylation of the SNAP25 protein family: specificity and regulation by DHHC palmitoyl transferases. J Biol Chem 285: 24629-24638.
34. Shmueli A, Segal M, Sapir T, Tsutsumi R, Noritake J, et al. (2010) Ndel1 palmitoylation: a new mean to regulate cytoplasmic dynein activity. EMBO J 29: 107-119.
35. Sharma C, Yang XH, Hemler ME, (2008) DHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151. Mol Biol Cell 19: 3415-3425.
36. Zhang J, Planey SL, Ceballos C, Stevens SM Jr, Keay SK, et al. (2008) Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method. Mol Cell Proteomics 7: 1378-1388.
37. Singaraja RR, Kang MH, Vaid K, Sanders SS, Vilas GL, et al. (2009) Palmitoylation of ATP-binding cassette transporter A1 is essential for its trafficking and function. Circ Res 105: 138-147.
38. Zeidman R, Buckland G, Cebecauer M, Eissmann P, Davis DM, et al. (2011) DHHC2 is a protein S-acyltransferase for Lck. Mol Membr Biol 28: 473-486.
39. Tsutsumi R, Fukata Y, Noritake J, Iwanaga T, Perez F, et al. (2009) Identification of G protein alpha subunit-palmitoylating enzyme. Mol Cell Biol 29: 435-447.
40. Jia L, Linder ME, Blumer KJ, (2011) Gi/o signaling and the palmitoyltransferase DHHC2 regulate palmitate cycling and shuttling of RGS7 family-binding protein. J Biol Chem 286: 13695-13703.
41. Fernandez-Hernando C, Fukata M, Bernatchez PN, Fukata Y, Lin MI, et al. (2006) Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase. J Cell Biol 174: 369-377.
42. Conrads TP, Tocci GM, Hood BL, Zhang CO, Guo L, et al. (2006) CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients. J Biol Chem 281: 37836-37843.
43. Keay S, Seillier-Moiseiwitsch F, Zhang CO, Chai TC, Zhang J, (2003) Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics 14: 107-115.
44. Zhang CO, Wang JY, Koch KR, Keay S, (2005) Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. J Urol 174: 2382-2387.